Zai Lab Limited
NASDAQ: ZLAB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ying Du
- Employees
- 1,869
- Headquarters
- Shanghai, China
- IPO year
- 2017
- Market cap
- $2.1B
- Website
- https://www.zailaboratory.com
Loading ZLAB…
Loading profile data…Frequently asked questions about ZLAB
What does Zai Lab Limited (ZLAB) do?
Operating primarily in Mainland China and Hong Kong, Zai Lab Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medical treatments. Their therapeutic portfolio spans oncology, autoimmune conditions, infectious diseases, and neurological disorders. Currently available products in thei...
Where does ZLAB trade?
Zai Lab Limited (ZLAB) trades on the NASDAQ Global Market.
What sector is ZLAB in?
Zai Lab Limited (ZLAB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zai Lab Limited?
Ying Du is the chief executive officer of Zai Lab Limited (ZLAB).
Where is Zai Lab Limited headquartered?
Zai Lab Limited is headquartered in China.
Does ZLAB pay a dividend?
Zai Lab Limited (ZLAB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZLAB go public?
Zai Lab Limited (ZLAB) completed its initial public offering in 2017.
Is ZLAB an ADR?
Yes — ZLAB is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Zai Lab Limited reporting and dividends follow the underlying issuer.